A randomized trial of four cycles of adjuvant AC (adriamycin plus cyclophosphamide) +/- two cycles of EP (etoposide plus cisplatin) in node positive patients with breast cancer


Icli F., Akbulut H., Dincol D., Onur H., Demirkazik A., Cam R., ...Daha Fazla

ANNALS OF ONCOLOGY, cilt.12, sa.7, ss.1011-1013, 2001 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 12 Konu: 7
  • Basım Tarihi: 2001
  • Doi Numarası: 10.1023/a:1011118004629
  • Dergi Adı: ANNALS OF ONCOLOGY
  • Sayfa Sayıları: ss.1011-1013

Özet

Background: Four cycles of AC have been accepted as the standard chemotherapy in breast cancer. In the present randomized study we aimed to assess the efficacy of adjuvant etoposide + cisplatin (EP) combination following four cycles of standard adriamycin + cyclophosphamide (AC) in premenopausal patients with operable breast cancer and axillary lymph node metastasis.